July 24, 2019
Zafgen
Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061
July 23, 2019
Jounce Therapeutics
Jounce Therapeutics Announces Update on Strategic Collaboration with Celgene Corporation
July 18, 2019
Agios Pharmaceuticals
Agios to Webcast Conference Call of Second Quarter 2019 Financial Results on August 1, 2019
July 18, 2019
Blueprint Medicines
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application for Avapritinib for the Treatment of PDGFRα D842V Mutant GIST and Fourth-Line GIST
July 18, 2019
MyoKardia
MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi